EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Nanotechnology-Driven Strategies in Osteosarcoma Advances in Treatment: Immunotherapy and Drug Delivery

Wenwen Su, Yuanyuan Li, Guang Yang, Yangyang Zhao, Xinhao Zhou, Guangyao Liu, Xu Huang, Muhammad Farhan Sohail, Irshad Hussain iD, Qihui Liu iD, Fangfang Chen iD

International Journal of Nanomedicine · 2025-10 · Volume 20 · 12913-12937

DOI: 10.2147/ijn.s549587 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Nanomedicine, 2025-10. Verfasst von Wenwen Su und 10 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Pathobiology, Ministry of Education, Nanomedicine and Translational Research Center, China-Japan Union Hospital of Jilin University…. Hauptthemen laut MEDLINE: Osteosarcoma, Immunotherapy, Bone Neoplasms, Drug Delivery Systems. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 170 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteosarcomaImmunotherapyBone NeoplasmsDrug Delivery SystemsHumansTumor MicroenvironmentAnimalsNanomedicineAntineoplastic AgentsNanoparticlesNanotechnologyTheranostic Nanomedicine

Stichwörter der Autor:innen

drug deliveryimmune regulationnanomaterialsosteosarcomatumor microenvironment

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Key Laboratory of Pathobiology, Ministry of Education, Nanomedicine and Translational Research Center, China-Japan Union Hospital of Jilin University, Changchun, 130033, People's Republic of China.
  • Jilin Cancer Hospital, Changchun, Jilin Province, 130012, People's Republic of China.
  • Department of Orthopedics, China-Japan Union Hospital of Jilin University, Changchun, 130033, People's Republic of China.
  • Department of Radiology, The First Hospital of Jilin University, Changchun, 130021, People's Republic of China.
  • Riphah Institute of Pharmaceutical Sciences (RIPS), Riphah International University, Lahore Campus, Lahore, 54000, Pakistan.
  • Department of Chemistry and Chemical Engineering, Syed Babar Ali School of Science and Engineering, Lahore University of Management Sciences, Lahore, Punjab, 54792, Pakistan.

ORCID-Profile: Irshad Hussain, Qihui Liu, Fangfang Chen

Zitieren

APA

Su, W., Li, Y., Yang, G., Zhao, Y., Zhou, X., Liu, G., Huang, X., Sohail, M. F., Hussain, I., Liu, Q., & Chen, F. (2025). Nanotechnology-Driven Strategies in Osteosarcoma Advances in Treatment: Immunotherapy and Drug Delivery. International Journal of Nanomedicine, Volume 20, 12913-12937. https://doi.org/10.2147/ijn.s549587

Vancouver

Su W, Li Y, Yang G, Zhao Y, Zhou X, Liu G, et al. Nanotechnology-Driven Strategies in Osteosarcoma Advances in Treatment: Immunotherapy and Drug Delivery. International Journal of Nanomedicine. 2025;Volume 20:12913-12937. doi:10.2147/ijn.s549587

BibTeX
@article{Su2025,
  author = {Su, Wenwen and Li, Yuanyuan and Yang, Guang and Zhao, Yangyang and Zhou, Xinhao and Liu, Guangyao and Huang, Xu and Sohail, Muhammad Farhan and Hussain, Irshad and Liu, Qihui and Chen, Fangfang},
  title = {Nanotechnology-Driven Strategies in Osteosarcoma Advances in Treatment: Immunotherapy and Drug Delivery},
  journal = {International Journal of Nanomedicine},
  year = {2025},
  volume = {Volume 20},
  pages = {12913--12937},
  doi = {10.2147/ijn.s549587}
}
Kostenlos starten →